308080 Stock Chart & Stats
₩6780.00
₩100.00(1.50%)
―
--
Day’s Range― - ―
52-Week Range₩3,070.00 - ₩17,360.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)196.59K
Market Cap
₩136.94B
Enterprise Value₩105.98K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.92
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-114.27
Shares Outstanding20,499,260
10 Day Avg. Volume393,820
30 Day Avg. Volume196,591
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
308080 FAQ
What was ViGenCell, Inc.’s price range in the past 12 months?
ViGenCell, Inc. lowest stock price was ₩3070.00 and its highest was ₩17360.00 in the past 12 months.
What is ViGenCell, Inc.’s market cap?
ViGenCell, Inc.’s market cap is ₩136.94B.
When is ViGenCell, Inc.’s upcoming earnings report date?
ViGenCell, Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 63 days.
How were ViGenCell, Inc.’s earnings last quarter?
ViGenCell, Inc. released its earnings results on Aug 14, 2026. The company reported -₩114.265 earnings per share for the quarter.
Is ViGenCell, Inc. overvalued?
According to Wall Street analysts ViGenCell, Inc.’s price is currently Undervalued.
Does ViGenCell, Inc. pay dividends?
ViGenCell, Inc. does not currently pay dividends.
What is ViGenCell, Inc.’s EPS estimate?
ViGenCell, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ViGenCell, Inc. have?
ViGenCell, Inc. has 20,499,260 shares outstanding.
What happened to ViGenCell, Inc.’s price movement after its last earnings report?
ViGenCell, Inc. reported an EPS of -₩114.265 in its last earnings report. Following the earnings report the stock price went down -1.468%.
Which hedge fund is a major shareholder of ViGenCell, Inc.?
Currently, no hedge funds are holding shares in KR:308080
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Technical Analysis
DongKoo Bio & Pharm Co. Ltd.
―
Genexine, Inc.
―
T&R Biofab Co., Ltd
―
TiumBio Co., Ltd.
―
Celemics, Inc.
―